Longeveron Inc. Files Definitive Proxy Statement

Ticker: LGVN · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1721484

Sentiment: neutral

Topics: proxy-statement, governance, annual-meeting

TL;DR

Longeveron proxy filed - vote on exec pay & board for June 13 meeting.

AI Summary

Longeveron Inc. filed its definitive proxy statement on April 28, 2025, for its annual meeting on June 13, 2025. The company, focused on pharmaceutical preparations, is seeking shareholder approval for various corporate matters. The filing details executive compensation, board nominations, and other governance issues relevant to its operations in Miami, FL.

Why It Matters

This filing provides shareholders with crucial information regarding company governance, executive compensation, and voting matters, enabling informed participation in the company's decision-making process.

Risk Assessment

Risk Level: medium — Proxy statements are routine filings, but the specific proposals and shareholder votes can impact company direction and stock performance.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this DEF 14A filing?

The primary purpose is to provide shareholders with information and solicit their votes for the annual meeting on June 13, 2025, covering matters such as board elections and executive compensation.

When is the Longeveron Inc. annual meeting scheduled?

The annual meeting is scheduled for June 13, 2025.

What is Longeveron Inc.'s Standard Industrial Classification (SIC) code?

Longeveron Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Where is Longeveron Inc. headquartered?

Longeveron Inc. is headquartered in Miami, FL, with its business and mailing address at 1951 NW 7th Avenue, Suite 520.

Was a filing fee paid for this proxy statement?

No fee was required for this filing.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Longeveron Inc. (LGVN).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing